• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global health

    Exclusive: IAS President ‘very upset’ over AIDS 2022 visa denials

    This year’s conference is happening in Montreal, Canada, but many were upset and frustrated over not being able to attend because they were denied visas or are still waiting for their applications to get approved.

    By Jenny Lei Ravelo // 27 July 2022
    A Canadian visa application form. Photo by: Mohammed Anwarul Kabir Choudhury / Alamy via Reuters Connect

    The president of the International AIDS Society says she’s “very upset” that many people were denied visas to attend the conference, whose main program starts on Friday.

    “We have all been working very hard to make this first in person conference since the COVID pandemic a big success,” Adeeba Kamarulzaman, IAS president and international co-chair of AIDS 2022, told Devex.

    “The AIDS conference has always been about inclusivity and participation from communities most affected, so to have many people denied from coming based on where they are coming from is naturally upsetting to me and an incredible loss to AIDS 2022,” she said.

    The 24th International AIDS Conference, the world’s biggest HIV and AIDS event, takes place every two years and is organized by the International AIDS Society. Policymakers, HIV and AIDS activists, scientists, and researchers come together to take stock of the latest science and galvanize action to address the epidemic, which has killed over 36 million people to date.

    This year’s conference is scheduled for July 29 to Aug. 2 in Montreal, Canada, but many were upset and expressed frustration for not being able to attend because they were denied visas or are still waiting for their applications to get approved.

    “Underlying the visa issue is a wider problem of global inequities and systemic racism that have a significant impact on global health.”

    — Adeeba Kamarulzaman, IAS president and international co-chair of AIDS 2022

    Winnie Byanyima, executive director of UNAIDS, tweeted on Tuesday that her documents were repeatedly scrutinized and she was “almost refused to board” the plane going to the event. Tian Johnson, an African activist and founder of the African Alliance for HIV Prevention, also tweeted that he won’t be attending the conference after he was refused to board the plane even after “nearly 20 thousand dollars in VISA fees, biometric costs, travel back & forth, public fights for VISA's.”

    Many have called the visa denials an act of racism on the part of Canada. Others raised questions over whether high-income countries should be chosen to host global health conferences when it’s known to be costly and challenging to get visas for people coming from low- and middle-income countries.

    Kamarulzaman said they will continue to do “everything we can” for Canadian authorities to expedite and approve visa applications for those attending the conference. She added that choosing a venue for such a large gathering takes into account many considerations, including the size of the venue, safety and human rights, independence in conference program planning, and financial viability to enable scholarships for a large number of participants.

    “Originally, the IAS had selected a middle-income country to host AIDS 2022. Unfortunately, the IAS had to pull out these negotiations as the host government made it a condition that it would vet and thereby influence the conference programme,” she said.

    “The Organizing Committee insists on full independence in putting together a programme that puts people first and is guided by the latest scientific evidence,” she added.

    The Tweet https://twitter.com/paimadhu/status/1551544060359368704 is not available.
    Via Twitter.

    She didn’t share which middle-income country the conference originally was supposed to take place in, only saying that it was located in Asia.

    Kamarulzaman said they do not have the number of people who were denied visas to attend the conference, but noted that participants unable to be there in person can still access the sessions virtually. She promised that registration costs would be refunded for participants traveling from LMICs, as long as their visas were denied and they applied more than 12 weeks before the start date of the conference.

    Asked whether they plan to host the next AIDS conference in an LMIC, she said selecting a host country is “not a straightforward matter,” and having a conference in an LMIC “does not necessarily mean that we overcome these visa issues either.” She did add that the IAS also hosts other conferences that take place in low- and middle-income settings.

    Nevertheless, she said the issues surrounding this year’s International AIDS Conference have taught organizers a “hard lesson.”

    “We … must not allow this to happen again,” she said, saying they’ll need to “re-evaluate how we may ensure that the IAC remains an inclusive event, especially for the communities most affected by HIV,” she said.

    “Underlying the visa issue is a wider problem of global inequities and systemic racism that have a significant impact on global health, particularly on HIV that has always disproportionately affected the most marginalized.”

    Read more:

    ►  New effort aims to measure — and improve — dignity in development

    ► Opinion: Here's how to stop global aid from being so condescending

    ► Opinion: Lessons from 17 years of trying to change the system

    • Global Health
    • Social/Inclusive Development
    • Trade & Policy
    • Humanitarian Aid
    • UNAIDS
    • AIDS 2022
    • Canada
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Munich Security Conference 2025Munich diary: The latest from the jam-packed security conference

    Munich diary: The latest from the jam-packed security conference

    Global healthHow Trump’s aid freeze is threatening tuberculosis programs

    How Trump’s aid freeze is threatening tuberculosis programs

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global HealthNoncommunicable diseases: A policy success but implementation failure

    Noncommunicable diseases: A policy success but implementation failure

    Most Read

    • 1
      Scoop: Funding cuts at UN children's agency fuel intense staff pushback
    • 2
      Opinion: Water can work for peace — but more investment is needed
    • 3
      Special edition: Germany steps into the void USAID left behind
    • 4
      The power to communicate: How to leverage AI in assistive technologies
    • 5
      Bridging the diagnostics gap in Africa with AI-powered solutions
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement